Carbowhite is an enterosorbent, the active ingredient of which is silicon dioxide.
Indications for use
As monotherapy or in combination therapy:
- acute intestinal diseases (salmonellosis, food poisoning);
- acute diarrhea of various etiologies;
- exogenous intoxication with household and industrial toxins (alkaloids, heavy metal salts, other substances), medications, and alcohol and food overloads.
As adjunctive therapy:
- with viral hepatitis;
- for allergic diseases;
- for dermatitis;
- with late gestosis of pregnant women.
Composition
- active ingredient: colloidal anhydrous silicon dioxide;
- 1 tablet contains 210 mg of colloidal anhydrous silicon dioxide (calculated on 100% dry matter);
- excipients: potato starch, microcrystalline cellulose, sorbitol (E 420), croscarmellose sodium, magnesium stearate.
Contraindication
Hypersensitivity to the active substance and to excipients. Gastric and duodenal ulcer in the acute stage. Ulcers and erosions of the intestinal mucosa. Gastric and intestinal bleeding. Intestinal obstruction.
Adverse reactions
No cases of adverse reactions were recorded when the method of administration was followed.
If the recommended doses are exceeded, isolated cases of constipation are possible.
Method of application
Take between meals, with drinking water:
- adults and children over 7 years old – 3-5 tablets 3-4 times a day;
- children aged 5-6 years – 3 tablets 3 times a day;
- Children aged 3-4 years – 2 tablets 3 times a day.
In severe cases, if necessary, a single dose can be increased to 10-14 tablets.
In acute intestinal diseases, the course of treatment is 3-5 days. In severe cases, the treatment period can be extended to 10-15 days.
The course of treatment for viral hepatitis depends on the severity of the disease and is 10-14 days.
The duration of treatment depends on the course of the disease.
Application features
Carbowhite, when used in complex therapy, should be taken 1 hour before taking other oral medications to prevent a decrease in their effectiveness.
Since the drug Carbowhite does not contain sugar, it can be used by patients with diabetes.
The medicine contains sorbitol, so it should not be used in patients with rare hereditary diseases such as fructose intolerance syndrome.
Children
The drug is not prescribed to children under 3 years of age.
Use during pregnancy or breastfeeding
The decision to take the drug Carbowhite during pregnancy and breastfeeding is made by a doctor, taking into account the benefit/risk ratio.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect.
Overdose
There were no reports of overdose.
Interaction with other medicinal products and other types of interactions
With the simultaneous use of Carbowhite and acetylsalicylic acid, platelet disaggregation processes may be enhanced.
In complex therapy with nicotinic acid and simvastatin, Carbowhite exhibits a synergistic effect: it helps reduce the level of atherogenic fractions of the blood lipid spectrum and increase the level of high-density lipoprotein cholesterol.
Storage conditions
In the original packaging at a temperature not exceeding 25C.
Keep out of reach of children.

















Reviews
There are no reviews yet.